Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Spectral AI, Inc. (MDAI)
USD1.70
+0.03 (+1.50%)
US NASDAQ Healthcare Medical - Specialties
Address
2515 McKinney Avenue 75201
Dallas, TX, US
Dallas, TX, US
CEO
Vincent S. Capone
Website
spectral-ai.com
IPO
2021-04-06
CIK 1833498 ISIN US84757T1051
Also trades on
NASDAQ Capital Market · MDAI (USD)
NASDAQ Capital Market · RCLF (USD)
NASDAQ Capital Market · RCLFU (USD)
NASDAQ Capital Market · RCLFW (USD)
Description
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.70
+0.03 (+1.50%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
645.4K
Beta
1.15
Float Shares
22.74M
Free Float %
71.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.73% | -3.59% | +24.28% | +42.38% | +34.38% | +51.41% | +58.09% | -79.33% | -77.90% | -77.84% | -77.84% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
1.70
Low
3.50
+106.5%
Consensus
3.50
+106.5%
Median
3.50
+106.5%
High
3.50
+106.5%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
3.50
+106.5%
|
Quality scores
Altman Z-Score
-2.53
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%-33.6% Q1'26: -40.5% (vs Q1'25)
-
EPS growth Medical - Specialties: +10.1%+65.9% ★ Q1'26: -200.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%-58.6% Q1'26: -93.4% (vs Q1'25)
-
EBIT margin Medical - Specialties: +12.6%-43.8% Q1'26: -74.8% (vs Q1'25)
-
ROIC Medical - Specialties: +6.6%— Q1'26: +113.1% (vs Q1'25)
-
Share dilution Medical - Specialties: 0.0%+47.9% Q1'26: +32.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-1.27× Q1'26: -0.88× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
18.06M
est: 22.53M (-19.9%)
|
29.58M
est: 28.65M (+3.3%)
|
19.65M
est: 18.48M (+6.3%)
|
18.71M
18.51M – 18.90M
+1.2% YoY
|
23.29M
17.10M – 29.47M
+24.5% YoY
|
8.43M
8.42M – 8.45M
-63.8% YoY
|
12.90M
9.03M – 16.70M
+53.0% YoY
|
18.20M
12.73M – 23.56M
+41.1% YoY
|
| EBITDA |
-20.12M
est: -9.69M (-107.7%)
|
-11.49M
est: -12.32M (+6.7%)
|
-7.97M
est: -7.95M (-0.3%)
|
-8.04M
-8.13M – -7.96M
-1.2% YoY
|
-10.01M
-12.67M – -7.35M
-24.5% YoY
|
-3.63M
-3.63M – -3.62M
+63.8% YoY
|
-5.55M
-7.18M – -3.88M
-53.0% YoY
|
-7.83M
-10.13M – -5.48M
-41.1% YoY
|
| EBIT |
-20.84M
est: -10.03M (-107.9%)
|
-12.08M
est: -12.75M (+5.2%)
|
-8.60M
est: -8.22M (-4.6%)
|
-8.32M
-8.41M – -8.24M
-1.2% YoY
|
-10.36M
-13.11M – -7.61M
-24.5% YoY
|
-3.75M
-3.76M – -3.74M
+63.8% YoY
|
-5.74M
-7.43M – -4.02M
-53.0% YoY
|
-8.10M
-10.48M – -5.67M
-41.1% YoY
|
| Net Income |
-20.85M
est: -33.37M (+37.5%)
|
-15.32M
est: -13.05M (-17.4%)
|
-7.57M
est: -12.42M (+39.0%)
|
-12.95M
-13.63M – -12.26M
-4.3% YoY
|
-14.14M
-17.14M – -11.14M
-9.2% YoY
|
-30.20M
-33.74M – -14.87M
-113.5% YoY
|
-2.12M
-2.93M – -1.29M
+93.0% YoY
|
—
— – —
+100.0% YoY
|
| SGA |
20.86M
est: 17.97M (+16.1%)
|
19.86M
est: 22.84M (-13.1%)
|
17.53M
est: 14.74M (+18.9%)
|
14.92M
14.76M – 15.07M
+1.2% YoY
|
18.57M
13.63M – 23.50M
+24.5% YoY
|
6.72M
6.71M – 6.73M
-63.8% YoY
|
10.29M
7.20M – 13.32M
+53.0% YoY
|
14.51M
10.16M – 18.79M
+41.1% YoY
|
| EPS |
-1.48
est: -1.26 (-17.2%)
|
-0.85
est: -0.50 (-71.2%)
|
-0.29
est: -0.47 (+38.3%)
|
-0.49
-0.51 – -0.46
-5.0% YoY
|
-0.53
-0.65 – -0.42
-8.1% YoY
|
-0.92
-1.27 – -0.56
-72.5% YoY
|
-0.08
-0.11 – -0.05
+91.3% YoY
|
—
— – —
+100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-10.44M
OE per share TTM
-0.39
Owner's Yield
-14.79%
Maintenance CapEx ratio
29.76%
Maint CapEx / Avg PPE
5.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
7
Total invested
1.63M
Insider transactions (90d)
4
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
7
-20 vs prev Q
New positions
0
Closed positions
20
Increased
2
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | HUDSON BAY CAPITAL MANAGEMENT LP | 1.53M +1.5M (+100.0%) | 2.17M +2.2M (+100.0%) | 5.80% +5.801 pp | 0.01% +0.007 pp | USD1.42 +0.0% | 1 qtrs NEW |
| 2 | HIGHLANDER PARTNERS, L.P. | 900.0K +— (+0.0%) | 1.28M -774.0K (-37.7%) | 3.42% -0.121 pp | 0.46% -0.257 pp | USD2.55 -44.3% | 10 qtrs — |
| 3 | VANGUARD GROUP INC | 842.0K +228.8K (+37.3%) | 1.20M -202.6K (-14.5%) | 3.20% +0.787 pp | 0.00% +0.000 pp | USD1.78 -20.2% | 8 qtrs — |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 216.6K +34.6K (+19.0%) | 307.6K -107.4K (-25.9%) | 0.82% +0.107 pp | 0.00% +0.000 pp | USD1.89 -24.9% | 10 qtrs — |
| 5 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 210.5K +— (+0.0%) | 298.9K -181.0K (-37.7%) | 0.80% -0.028 pp | 0.04% -0.027 pp | USD2.57 -44.7% | 10 qtrs — |
| 6 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 199.0K +— (+0.0%) | 282.6K -171.1K (-37.7%) | 0.76% -0.027 pp | 0.01% -0.004 pp | USD1.29 +10.1% | 4 qtrs — |
| 7 | DNB ASSET MANAGEMENT AS | 136.5K +62.8K (+85.2%) | 193.8K +25.7K (+15.3%) | 0.52% +0.229 pp | 0.00% +0.000 pp | USD1.95 -27.2% | 3 qtrs — |
| 8 | BLACKROCK, INC. | 117.5K +9.6K (+8.9%) | 166.8K -79.1K (-32.2%) | 0.45% +0.022 pp | 0.00% +0.000 pp | USD1.98 -28.3% | 6 qtrs — |
| 9 | UBS GROUP AG | 102.6K -83.1K (-44.7%) | 145.7K -277.6K (-65.6%) | 0.39% -0.341 pp | 0.00% +0.000 pp | USD2.39 -40.6% | 9 qtrs — |
| 10 | RATHBONES GROUP PLC | 89.2K +— (+0.0%) | 126.6K -76.7K (-37.7%) | 0.34% -0.012 pp | 0.00% 0.000 pp | USD2.57 -44.7% | 10 qtrs — |
| 11 | STATE STREET CORP | 75.6K +36.0K (+90.9%) | 107.4K +17.1K (+18.9%) | 0.29% +0.132 pp | 0.00% +0.000 pp | USD1.99 -28.6% | 7 qtrs — |
| 12 | FORUM FINANCIAL MANAGEMENT, LP | 60.5K +— (+0.0%) | 85.9K -52.0K (-37.7%) | 0.23% -0.008 pp | 0.00% -0.001 pp | USD2.15 -34.0% | 7 qtrs — |
| 13 | VIRTU FINANCIAL LLC | 52.5K +52.5K (+100.0%) | 75.0K +75.0K (+100.0%) | 0.20% +0.200 pp | 0.00% +0.003 pp | USD1.42 +0.0% | 1 qtrs NEW |
| 14 | JANE STREET GROUP, LLC | 52.6K +52.6K (+100.0%) | 74.7K +74.7K (+100.0%) | 0.20% +0.200 pp | 0.00% +0.000 pp | USD1.42 +0.0% | 5 qtrs — |
| 15 | SHAY CAPITAL LLC | 40.9K +— (+0.0%) | 58.0K -35.1K (-37.7%) | 0.16% -0.006 pp | 0.01% -0.002 pp | USD1.52 -6.6% | 7 qtrs — |
| 16 | NORTHERN TRUST CORP | 32.1K +793.0 (+2.5%) | 45.6K -25.8K (-36.1%) | 0.12% -0.001 pp | 0.00% +0.000 pp | USD1.98 -28.3% | 5 qtrs — |
| 17 | N.E.W. ADVISORY SERVICES LLC | 14.0K +14.0K (+100.0%) | 19.9K +19.9K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.002 pp | USD1.42 +0.0% | 1 qtrs NEW |
| 18 | PHILIP JAMES WEALTH MANGEMENT, LLC | 12.0K +— (+0.0%) | 17.0K -10.3K (-37.7%) | 0.05% -0.002 pp | 0.00% -0.001 pp | USD2.28 -37.7% | 2 qtrs — |
| 19 | MORGAN STANLEY | 8.4K -211.0 (-2.5%) | 11.9K -7.7K (-39.2%) | 0.03% -0.002 pp | 0.00% +0.000 pp | USD1.10 +29.1% | 10 qtrs — |
| 20 | ADVISOR GROUP HOLDINGS, INC. | 8.0K +— (+0.0%) | 11.3K -4.1K (-26.4%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD2.16 -34.3% | 10 qtrs — |
| 21 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.9K +3.9K (+100.0%) | 5.6K +5.6K (+100.0%) | 0.02% +0.015 pp | 0.00% +0.000 pp | USD1.42 +0.0% | 9 qtrs — |
| 22 | WESTSIDE INVESTMENT MANAGEMENT, INC. | 2.7K +— (+0.0%) | 3.8K -2.3K (-37.7%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD1.54 -7.8% | 7 qtrs — |
| 23 | NEWEDGE ADVISORS, LLC | 1.7K +— (+0.0%) | 2.4K -1.5K (-37.7%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD2.33 -39.1% | 8 qtrs — |
| 24 | WOLVERINE ASSET MANAGEMENT LLC | 1.7K +1.7K (+100.0%) | 2.4K +2.4K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD1.42 +0.0% | 1 qtrs NEW |
| 25 | CONCORD WEALTH PARTNERS | 300.00 +300.0 (+100.0%) | 426.00 +426.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD1.42 +0.0% | 1 qtrs NEW |
| 26 | BANK OF AMERICA CORP /DE/ | 119.00 +1.0 (+0.8%) | 169.00 -100.0 (-37.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.13 -33.3% | 10 qtrs — |
| 27 | SBI SECURITIES CO., LTD. | 1.00 +— (+0.0%) | 1.00 -1.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +42.0% | 5 qtrs — |
| 28 | FEDERATED HERMES, INC. | — -451.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 29 | MARSHALL WACE, LLP | — -145.5K (-100.0%) | — -331.7K (-100.0%) | 0.00% -0.572 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 30 | QUADRATURE CAPITAL LTD | — -11.9K (-100.0%) | — -27.3K (-100.0%) | 0.00% -0.047 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 31 | RAYMOND JAMES FINANCIAL INC | — -12.8K (-100.0%) | — -29.2K (-100.0%) | 0.00% -0.050 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 158.2K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 500.8K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 3.2K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 8.8K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 652.34 | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 1.51M | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 3.3K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.8K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 727.49 | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 80.14 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
136.1K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+136,098
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | Snyder Marion Ann | Director | A-Award | A | Common Stock | 25,000 | 0.00 | — | 25,000 | D | ↗ |
| 2026-04-24 | DiMaio John Michael | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 2,611,227 | D | ↗ |
| 2026-04-24 | Cotton Richard John | Director | A-Award | A | Common Stock | 29,850 | 0.00 | — | 96,777 | D | ↗ |
| 2026-04-24 | Capone Vincent S. | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 286,450 | D | ↗ |
| 2026-03-27 | DiMaio John Michael | Director | A-Award | A | Common Stock | 7,619 | 1.58 | 12.0K | 2,511,227 | D | ↗ |
| 2026-03-27 | Capone Vincent S. | Officer | A-Award | A | Common Stock | 16,750 | 1.52 | 25.5K | 186,450 | D | ↗ |
| 2025-06-10 | DiMaio John Michael | Director | A-Award | A | Common Stock | 9,700 | 2.11 | 20.5K | 2,503,608 | D | ↗ |
| 2025-06-09 | DiMaio John Michael | Director | A-Award | A | Common Stock | 2,000 | 2.10 | 4.2K | 2,493,908 | D | ↗ |
| 2025-06-04 | Mellish Martin C.B. | Director | A-Award | A | Common Stock | 5,000 | 1.73 | 8.7K | 24,398 | D | ↗ |
| 2025-04-30 | Mellish Martin C.B. | Director | A-Award | A | Common Stock | 9,699 | 0.00 | — | 19,398 | D | ↗ |
| 2025-04-30 | Cotton Richard John | Director | A-Award | A | Common Stock | 9,699 | 0.00 | — | 66,927 | D | ↗ |
| 2025-04-30 | Capone Vincent S. | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 119,700 | D | ↗ |
| 2024-05-15 | SPANGENBERG ERICH | Director / 10% Owner | A-Award | A | Common Stock | 6,000 | 1.74 | 10.4K | 628,574 | — | ↗ |
| 2024-05-10 | Sparks Jeremiah A. | Officer | A-Award | A | Common Stock | 6,084 | 1.65 | 10.0K | 16,084 | — | ↗ |
| 2024-05-10 | SPANGENBERG ERICH | Director / 10% Owner | A-Award | A | Common Stock | 45,000 | 1.77 | 79.7K | 622,574 | — | ↗ |
| 2024-05-10 | Micek Stan | Officer | A-Award | A | Common Stock | 10,000 | 1.72 | 17.2K | 10,000 | — | ↗ |
| 2024-05-10 | DiMaio John Michael | Director / 10% Owner | P-Purchase | A | Common Stock | 6,000 | 1.72 | 10.3K | 2,491,908 | — | ↗ |
| 2024-05-10 | Carlson Peter M | Director / Officer | A-Award | A | Common Stock | 29,411 | 1.74 | 51.2K | 29,411 | — | ↗ |
| 2024-05-10 | Capone Vincent S. | Officer | A-Award | A | Common Stock | 10,000 | 1.73 | 17.3K | 19,700 | — | ↗ |
| 2024-01-19 | DiMaio John Michael | Director / 10% Owner | L-Small | A | Common Stock | 2,000 | 2.20 | 4.4K | 2,485,908 | — | ↗ |
| 2024-01-09 | DiMaio John Michael | Director / 10% Owner | L-Small | A | Common Stock | 2,000 | 2.69 | 5.4K | 2,483,908 | — | ↗ |
| 2023-11-20 | DiMaio John Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 2,000 | 2.67 | 5.3K | 2,481,908 | — | ↗ |
| 2023-11-17 | Cotton Richard John | Director | A-Award | A | Common Stock | 14,650 | 2.67 | 39.1K | 47,529 | — | ↗ |
| 2023-11-16 | DiMaio John Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 500 | 2.68 | 1.3K | 2,479,908 | — | ↗ |
| 2023-11-14 | DiMaio John Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 355 | 2.81 | 997.55 | 2,479,408 | — | ↗ |
| 2023-09-13 | DiMaio John Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 198 | 5.07 | 1.0K | 2,479,053 | — | ↗ |
| 2023-09-12 | DiMaio John Michael | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 1,000 | 5.97 | 6.0K | 2,478,855 | — | ↗ |
| 2023-09-11 | Windler Nils | Officer | J-Other | A | NON-QUALIFIED STOCK OPTION | 6,466 | 4.54 | 29.4K | 116,391 | — | ↗ |
| 2023-09-11 | Thatcher Jeffrey Edward | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-11 | SPANGENBERG ERICH | 10% Owner | — | D | COMMON STOCK | 0 | 0.00 | — | 577,574 | — | ↗ |
| 2023-09-11 | Rosecliff Acquisition Sponsor I LLC | Director | M-Exempt | A | Common Stock | 815,000 | 0.00 | — | 815,000 | — | ↗ |
| 2023-09-11 | Radecki Brian J | Director | M-Exempt | D | Class B Common Stock | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2023-09-11 | Pagoulatos Nikolaos | Officer | J-Other | A | INCENTIVE STOCK OPTION | 78,643 | 3.82 | 300.4K | 78,643 | — | ↗ |
| 2023-09-11 | Mellish Martin C.B. | Director | J-Other | A | RESTRICTED STOCK UNITS | 19,398 | 4.49 | 87.1K | 19,398 | — | ↗ |
| 2023-09-11 | Fan Wensheng | Director / Officer | J-Other | A | INCENTIVE STOCK OPTION | 342,192 | 2.17 | 742.6K | 1,564,304 | — | ↗ |
| 2023-09-11 | Edmonds Franklin S. Jr. | Director | M-Exempt | D | Class B Common Stock | 20,000 | 0.00 | — | 0 | — | ↗ |
| 2023-09-11 | DiMaio John Michael | 10% Owner | — | D | COMMON STOCK | 0 | 0.00 | — | 2,477,855 | — | ↗ |
| 2023-09-11 | Cotton Richard John | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-11 | Capone Vincent S. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-11 | CAI XIAOJIA CYNTHIA | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-11 | Bellini Heather | Director | M-Exempt | D | Class B Common Stock | 20,000 | 0.00 | — | 0 | — | ↗ |
| 2023-01-04 | GOLDMAN SACHS GROUP INC | 10% Owner | S-Sale | D | Warrant | 1,461 | 0.00 | — | 322,041 | — | ↗ |
| 2022-12-23 | GOLDMAN SACHS GROUP INC | 10% Owner | — | I | Warrant | 340,782 | 0.00 | — | 0 | — | ↗ |
| 2021-05-21 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 1,125 | 9.89 | 11.1K | 2,512,808 | — | ↗ |
| 2021-05-06 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 15,000 | 10.00 | 150.0K | 2,513,977 | — | ↗ |
| 2021-05-05 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 15,000 | 10.00 | 150.0K | 2,532,656 | — | ↗ |
| 2021-05-04 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 45,044 | 9.99 | 450.0K | 2,547,656 | — | ↗ |
| 2021-04-29 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 1,450 | 10.00 | 14.5K | 2,592,700 | — | ↗ |
| 2021-04-16 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 577 | 10.00 | 5.8K | 2,594,150 | — | ↗ |
| 2021-04-15 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 12,333 | 10.00 | 123.3K | 2,594,727 | — | ↗ |
| 2021-04-14 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 20,000 | 9.98 | 199.6K | 2,607,060 | — | ↗ |
| 2021-04-13 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 8,032 | 9.98 | 80.2K | 2,627,060 | — | ↗ |
| 2021-04-09 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 20,000 | 9.97 | 199.4K | 2,635,092 | — | ↗ |
| 2021-04-08 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 20,000 | 9.95 | 199.0K | 2,655,092 | — | ↗ |
| 2021-04-07 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 2,435 | 9.95 | 24.2K | 2,675,092 | — | ↗ |
| 2021-04-06 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 1,965 | 9.95 | 19.6K | 2,677,527 | — | ↗ |
| 2021-04-05 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 12,139 | 9.95 | 120.8K | 2,679,492 | — | ↗ |
| 2021-04-01 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 9,346 | 9.95 | 93.0K | 2,691,631 | — | ↗ |
| 2021-03-24 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 31,600 | 9.90 | 312.8K | 2,700,977 | — | ↗ |
| 2021-03-23 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 41 | 9.95 | 407.95 | 2,732,577 | — | ↗ |
| 2021-02-12 | GLAZER CAPITAL, LLC | 10% Owner | — | I | Class A Common Stock | 0 | 0.00 | — | 2,732,618 | — | ↗ |
| 2021-02-11 | Zimmerman Jordan | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-02-11 | Rosecliff Acquisition Sponsor I LLC | Director / Officer / 10% Owner | — | D | Class B common stock | 6,195,000 | 0.00 | — | 0 | — | ↗ |
| 2021-02-11 | Radecki Brian J | Director | — | D | Class B common stock | 50,000 | 0.00 | — | 0 | — | ↗ |
| 2021-02-11 | Goodwin Kieran | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-02-11 | Edmonds Franklin S. Jr. | Director | — | D | Class B common stock | 40,000 | 0.00 | — | 0 | — | ↗ |
| 2021-02-11 | Bellini Heather | Director | — | D | Class B common stock | 40,000 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-126.5K
Shares Outstanding
31.82M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Wensheng Fan | Co-Founder, Chief Innovation Strategist & Senior Advisor to the Chief Executive Officer | 1M | male |
| Vincent Stanley Capone | CEO & Corporate Secretary | 733.5K | male |
| David McGuire | Chief Financial Officer | 479.8K | male |
| Stan Micek | Chief Operating Officer | 468.0K | male |
| Louis Percoco | General Manager | 422.7K | male |
| John Michael DiMaio | Founder & Chairman | 200.0K | — |
| Allison Kumar | Head of Regulatory Affairs & Clinical Trials | — | female |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MDAI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
